Fig. 2.
Changes in: a serum insulin concentration (ΔSSSI; p=0.6 placebo, p<0.0001 salsalate, follow-up vs baseline by paired t test; p<0.0001 placebo vs salsalate by ANCOVA); b GIR (ΔGIR; p=0.9 placebo, p=0.004 salsalate; p=0.04 placebo vs salsalate); c EGP (ΔEGP; p=0.3 placebo, p=0.5 salsalate; p=0.9 placebo vs salsalate); and d Rd (ΔRd, adjusted for steady-state glucose; p=0.7 placebo, p=0.003 salsalate; p=0.02 placebo vs salsalate) during euglycaemic hyperinsulinaemia after treatment with placebo or salsalate. Data boxes display median (solid line), mean (dotted line), quartiles (box), and 10th and 90th percentiles (error bars)